ACRS - Aclaris Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACRS is currently covered by 6 analysts with an average price target of $10.86. This is a potential upside of $7.03 (183.55%) from yesterday's end of day stock price of $3.83.

Aclaris Therapeutics's activity chart (see below) currently has 75 price targets and 92 ratings on display. The stock rating distribution of ACRS is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.36% with an average time for these price targets to be met of 116.57 days.

Highest price target for ACRS is $16, Lowest price target is $4, average price target is $10.86.

Most recent stock forecast was given by ALEX THOMPSON from STIFEL on 08-May-2026. First documented stock forecast 02-Nov-2015.

Currently out of the existing stock ratings of ACRS, 10 are a BUY (83.33%), 2 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 06-Nov-2024

$4

$0.17 (4.44%)

$3

5 months 2 days ago
(08-May-2026)

4/5 (80%)

$-0.93 (-18.86%)

50

Buy Since 05-May-2026

$11

$7.17 (187.21%)

$6

5 months 5 days ago
(05-May-2026)

1/2 (50%)

$6.25 (131.58%)

391

Buy Since 29-Nov-2016

$12

$8.17 (213.32%)

5 months 5 days ago
(05-May-2026)

0/2 (0%)

$7.25 (152.63%)

Buy Since 28-May-2025

$10

$6.17 (161.10%)

$8

5 months 11 days ago
(29-Apr-2026)

0/3 (0%)

$5.53 (123.71%)

Buy Since 14-May-2025

$16

$12.17 (317.75%)

$16

5 months 25 days ago
(15-Apr-2026)

0/10 (0%)

$12.07 (307.12%)

Show more analysts

Please expand the browser size to see the chart

What is ACRS (Aclaris Therapeutics) average time for price targets to be met?

On average it took 117 days for the stock forecasts to be reached, with an average price target met ratio of 23.36%.

Which analyst most recently updated their price target on ACRS (Aclaris Therapeutics)?

Alex Thompson

Which analyst has the most public recommendations on ACRS (Aclaris Therapeutics)?

Alex Thompson works at STIFEL and has 6 price targets and 7 ratings on ACRS

Which analyst is the currently most bullish on ACRS (Aclaris Therapeutics)?

David Steinberg with the highest potential upside of $29.17

Which analyst is the currently most reserved on ACRS (Aclaris Therapeutics)?

Alex Thompson with the lowest potential downside of -$3
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?